One might expect that an increased State and Local Tax (SALT) deduction cap in the new tax bill would be front and center for ...

At the recent Pinnacle Summit, four fund managers reveal their top ASX stock picks focusing on fundamentals and long-term ...

Opportunities in traditional pharma companies with a focus on domestic formulations and US generics are drying up because of ...

Improving domestic growth, rising liquidity, and potential rate cuts are expected to aid recovery, but the ‘real concern is ...

Investors looking for hidden gems should keep an eye on small-cap stocks because they’re frequently overlooked by Wall Street ...

Fidelity reviews Q2 for its International Small Cap Fund, highlighting key wins and misses. See how it's adapting to global shifts. Explore the full update.

You don't have to be Warren Buffett to build generational wealth in the stock market. All you need to do is focus on ...

Ophir Asset Management’s Aussie small cap fund returned 39 per cent last financial year. Here’s where they’re investing this ...

There is significant upside to IonQ's stock, given that it's only an $11 billion company yet competes in a market that could be worth $87 billion by 2035. That's huge projected growth, and if IonQ can ...

The One Big Beautiful Bill Act (OBBBA), enacted July 4, 2025, made a number of changes to the Internal Revenue Code of 1986, as amended (the ...

Just because you missed out on the huge rally in the S&P 500 since April 8 doesn't mean it's necessarily a bad time to put ...

It’s one of the most explosive sectors in the market — but also one of the riskiest. Biotech investors, beware. Small-cap biotech stocks can be extremely volatile… but if you know what to look for, ...